SOURCE: ZELTIQ Aesthetics, Inc.

February 02, 2015 16:05 ET

ZELTIQ to Present at Investor Conferences in February 2015

PLEASANTON, CA--(Marketwired - Feb 2, 2015) - ZELTIQ®, (NASDAQ: ZLTQ) a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer, and Patrick F. Williams, Senior Vice President and Chief Financial Officer, are scheduled to participate in two investor conferences in February 2015.

Event:  2015 Leerink Global Healthcare Conference
Format: Presentation and One-on-One Meetings
Date:
 Wednesday, February 11, 2015
Time:  3:05 p.m. ET / 12:05 p.m. PT

Event:  BTIG 2nd Annual Snowbird Conference
Format: One-on-One Meetings Only
Date:
 Wednesday, February 18, 2015

An audio webcast of the Company's presentation will be available by visiting the investor relations section of ZELTIQ's web site at www.coolsculpting.com. A replay of the presentation will be available for 90 days.

About ZELTIQ® Aesthetics
ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting® System, is designed to selectively reduce stubborn fat bulges. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer.